Skip to main content
Cenra Inc. logo

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 ISIN · TW0003716007 TW Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2024-11-08 Director's Dealing
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
113年10月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders such as directors, managers, and related parties. It includes specific data on shares held, increases, decreases, and trust shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate announcements. There is no indication of it being a full financial report, earnings release, or regulatory certification. The document is a report of personal share transactions by company directors and executives, fitting the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data, not just an announcement or summary.
2024-11-08 Chinese
公告本公司113年第3季合併財務報告董事會召開日期
Regulatory Filings Classification · 95% confidence The document is a short announcement (538 characters) from a company (3716 中化控股) stating the date of the board meeting to be held on 113/11/08 to discuss the 3rd quarter consolidated financial report. It does not contain the financial report itself but only announces the upcoming board meeting and the expected report to be presented. This fits the pattern of a Regulatory Filing (RNS) as it is a general regulatory announcement about corporate events and report scheduling, not the report itself or a detailed financial document.
2024-10-30 Chinese
公告本公司原訂於113年10月30日起至113年11月1日止 採電子投票方式之股東領取紀念品，如遇颱風停班影響， 發放日將依停班天數順延至下一個營業日
Regulatory Filings Classification · 95% confidence The document is a short announcement (858 characters) from a company regarding the schedule adjustment for shareholders to collect commemorative gifts due to a typhoon affecting the electronic voting period for a shareholders' meeting. It does not contain financial data, management discussion, or detailed report content. It is related to shareholder meeting logistics but does not present voting results or meeting materials. The document is an operational announcement about shareholder meeting arrangements, not a report or detailed filing. Given its nature and length, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-10-30 Chinese
公告本公司股東臨時會決議解除董事及其代表人 競業禁止之限制。
Board/Management Information Classification · 95% confidence The document is a company announcement from 中化控股 (stock code 3716) regarding a shareholders' meeting resolution to lift non-compete restrictions on certain directors and their representatives. It details the names, titles, and permitted competitive activities of directors, the voting results, and related information. The document is short (2035 characters) and focuses on a specific board/management-related decision rather than financial results or reports. There is no financial data or report attached or referenced as being published. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions related to the company's board or senior management.
2024-10-29 Chinese
公告本公司董事會通過委任第一屆審計委員會委員。
Board/Management Information Classification · 95% confidence The document is a public announcement from a listed company (3716 中化控股) regarding the appointment of members to the first Audit Committee. It details the names, titles, and brief resumes of the new appointees, the date of appointment, and the nature of the change (new appointment). There is no financial data, no report attached or referenced, and no mention of voting results or shareholder meetings. The content is about changes in a company's board-level committee members, which falls under Board/Management Information (MANG). The document length is short and focused solely on management changes, not an audit report or annual report. Therefore, the correct classification is MANG with high confidence.
2024-10-29 Chinese
公告本公司董事會通過委任第一屆薪資報酬委員會委員。
Board/Management Information Classification · 100% confidence The document is a short announcement (733 characters) about the appointment of members to the company's first Compensation Committee, including names and brief resumes. It is a disclosure of changes in the company's board-related committees, specifically about management or board appointments. There is no financial data, no report attached or referenced, and no mention of voting results or other report types. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2024-10-29 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.